SEARCH RESULTS
Your search for "" returned the following 530 results.
Imaged-based high-throughput screening for anti-angiogenic drug discovery (2010)
Evensen L, Link W, Lorens JB. Curr Pharm Des. 2010;16(35):3958-63.PMID: 21158729 Please click here for more information.
Read MoreEfficient in vivo vascularization of tissue-engineering scaffolds (2010)
J Tissue Eng Regen Med. 2011 Apr;5(4):e52-62. doi: 10.1002/term.336. Epub 2010 Sep 23. Please click here for more information.
Read MoreHigh content screening: seeing is believing (2010)
Trends Biotechnol. 2010 May;28(5):237-45. doi: 10.1016/j.tibtech.2010.02.005. Epub 2010 Mar 24. Please click here for more information.
Read MoreAxl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival (2009)
Gjerdrum C, Tiron C, Høiby T, Stefansson I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT, Micklem DR, Akslen LA, Glackin C, Lorens JB. Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1124-9. Epub 2009 Dec 28.PMID: 20080645 Please click here for more information.
Read MoreAxl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival (2009)
Gjerdrum, C., Tiron, C.E., Micklem, D.R., Høiby, T., Steffansson, I., Haugen, H, Sandal, T., McCormack, E., Gjertsen, B.T., Akslen, L., C. Glackin and Lorens, J.B. (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl. Acad. Sci. USA, 107: 1124-1129 Please click here for more information. Press coverage: Lou K-J (2010) Breaking the…
Read MoreCarfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome (2009)
Parlati F, Lee SJ, Aujay M, Suzuki E, Levitsky K, Lorens JB, Micklem DR, Ruurs P, Sylvain C, Lu Y, Shenk KD, Bennett MK. Blood. 2009 Oct 15;114(16):3439-47. Epub 2009 Aug 11.PMID: 19671918 Please click here for more information.
Read More
